Furthermore, in the context of gut microbiota dysregulation, the increased levels of SREBP2 and heightened expression of cholesterol synthesis-related genes are associated with the reduction of tryptophan metabolites and weakened AhR activation, contributing to the initiation of liver cancer (Chen W. et al., 2022). This evidence concerns the gene SREBF2 and liver cancer.